Activity, Motor Control & Coordination
Pain - Thermal Allodynia / Hyperalgesia
Pain - Spontaneous Pain - Postural Deficit
Pain - Mechanical Allodynia / Hyperalgesia
Anxiety & Depression Disorder
Learning/Memory - Attention - Addiction
Physiology & Respiratory Research
Metabolism - Food & Drink Intake
Pain
Central Nervous System (CNS)
Neurodegeneration
Sensory system
Motor control
Mood Disorders
Other disorders
Muscular system
Joints
Metabolism
Cross-disciplinary subjects
SFN2024: Meet our team in Chicago on booth #876 Authors
Y Zhang, F Huang, Y Xu et al
Lab
Department of Anesthesiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, PeopleÕs Republic of China
Journal
All Life
Abstract
Paclitaxel-induced peripheral neuropathic pain (PIPNP) is a major therapy- and dose-limiting side effect that is extremely laborious to treat. Resveratrol (Res), with a structure name of 3,5,40-trihydroxystilbene, is a kind of natural polyphenolic chemical with plenty of useful characteristics such as anti-inflammatory, and anti-oxidative stress. However, the impact of Res on PIPNP remains unclear. Therefore, the current study intends to examine the analgesic effect of Res on PIPNP. In the present study, the results revealed that Res could effectively prevent the development of paclitaxelinduced PIPNP in a dose-dependent manner when repeated doses of Res were given during PIPNP induction. This prophylactic effect of Res was involved in inhibited paclitaxel-induced up-regulation of TRPV1 instead of TRPA1 in the dorsal root ganglia. Furthermore, the inhibition of TRPV1 upregulation by Res may be involved in a phosphorylation of ERK mechanism. In summary, we conclude that Res plays an intriguing role in the prevention of PIPNP and thus may work as a therapeutic compound for treating and preventing PIPNP.
BIOSEB Instruments Used:
Cold Hot Plate Test (BIO-CHP)
